{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:44:31Z","timestamp":1791409471595,"version":"4.3.3"},"reference-count":193,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.semcancer.2013.08.011","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T20:17:16Z","timestamp":1378585036000},"page":"71-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":259,"special_numbering":"C","title":["The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies"],"prefix":"10.1016","volume":"24","author":[{"given":"Jan A.","family":"Burger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Gribben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2013.08.011_bib0005","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0010","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-06-1204","article-title":"Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma","volume":"12","author":"Ruan","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0015","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0020","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","article-title":"Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia","volume":"110","author":"Burkle","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2141.2011.08747.x","article-title":"Nurse-like cells show deregulated expression of genes involved in immunocompetence","volume":"154","author":"Bhattacharya","year":"2011","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0030","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y","article-title":"Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22","volume":"32","author":"Ghia","year":"2002","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0035","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","article-title":"CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment","volume":"111","author":"Patten","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0040","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/28.8.7003001","article-title":"Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas","volume":"28","author":"Stein","year":"1980","journal-title":"Journal of Histochemistry and Cytochemistry"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2141.1996.00305.x","article-title":"Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro","volume":"92","author":"Panayiotidis","year":"1996","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0050","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1182\/blood.V91.7.2387","article-title":"Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells","volume":"91","author":"Lagneaux","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0055","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2011-08-371203","article-title":"Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells","volume":"119","author":"Hwang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0060","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0065","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0070","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1182\/blood-2009-04-217687","article-title":"Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy","volume":"114","author":"Ramsay","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0080","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1034\/j.1600-065X.2000.00618.x","article-title":"Follicular stromal cells and lymphocyte homing to follicles","volume":"176","author":"Cyster","year":"2000","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0090","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.immuni.2008.04.007","article-title":"New insights into the early molecular events underlying B cell activation","volume":"28","author":"Harwood","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0095","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcp.1040910303","article-title":"Conditions controlling the proliferation of haemopoietic stem cells in vitro","volume":"91","author":"Dexter","year":"1977","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0105","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1073\/pnas.79.11.3608","article-title":"Long-term culture of B lymphocytes and their precursors from murine bone marrow","volume":"79","author":"Whitlock","year":"1982","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0110","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0115","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2009-07-233718","article-title":"Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance","volume":"114","author":"Kurtova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF02889031","article-title":"Symbiotic culture of mouse leukaemias: regulation of cell interaction by an activity of serum","volume":"32","author":"Hiai","year":"1980","journal-title":"Virchows Archiv B: Cell Pathology Including Molecular Pathology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1083\/jcb.119.3.653","article-title":"Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture","volume":"119","author":"Miyake","year":"1992","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/scd.2012.0255","article-title":"Study of the quantitative, functional, cytogenetic and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia","volume":"22","author":"Pontikoglou","year":"2013","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0135","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood-2012-08-447813","article-title":"Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia","volume":"121","author":"Fecteau","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2141.2009.07868.x","article-title":"Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression","volume":"147","author":"Ding","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0145","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1182\/blood-2010-02-269894","article-title":"Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch","volume":"116","author":"Ding","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2012.12.003","article-title":"Protein kinase c-beta-dependent activation of NF-kappaB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo","volume":"23","author":"Lutzny","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0155","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2006-05-020800","article-title":"Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis","volume":"109","author":"Ame-Thomas","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0160","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","article-title":"Distinctive features of \u201cnurselike\u201d cells that differentiate in the context of chronic lymphocytic leukemia","volume":"99","author":"Tsukada","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0165","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1182\/blood-2011-12-395939","article-title":"RhoH is critical for cell\u2013microenvironment interactions in chronic lymphocytic leukemia in mice and humans","volume":"119","author":"Troeger","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0170","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2012-05-431452","article-title":"Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor","volume":"121","author":"Reinart","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0175","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood-2004-03-0889","article-title":"Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha","volume":"106","author":"Nishio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0180","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood-2004-10-3873","article-title":"CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival","volume":"105","author":"Deaglio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0185","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0195","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/leu.2012.63","article-title":"Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia","volume":"26","author":"Sivina","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0200","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0205","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0210","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1172\/JCI24176","article-title":"Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8T cells","volume":"115","author":"Gorgun","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0215","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Ramsay","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0220","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","article-title":"Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer","volume":"120","author":"Ramsay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0225","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2012-08-448332","article-title":"Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide","volume":"121","author":"Ramsay","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0230","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2005-02-0642","article-title":"Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine","volume":"106","author":"Beyer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0235","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.leukres.2008.08.021","article-title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","volume":"33","author":"Pallasch","year":"2009","journal-title":"Leukemia Research"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0240","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1182\/blood-2010-12-324210","article-title":"A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease","volume":"117","author":"Bagnara","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0245","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V63.2.305.305","article-title":"Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells","volume":"63","author":"Kay","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.2830240207","article-title":"Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2","volume":"24","author":"Kay","year":"1987","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ajh.2830300203","article-title":"Malignant chronic lymphocytic leukemia B cells elaborate soluble factors that down-regulate T cell and NK function","volume":"30","author":"Burton","year":"1989","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0260","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000203709","article-title":"Defective natural killer cell activity in B-cell chronic lymphocytic leukaemia is associated with impaired release of natural killer cytotoxic factor(s) but not of tumour necrosis factor-alpha","volume":"96","author":"Katrinakis","year":"1996","journal-title":"Acta Haematologica"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0265","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/leu.2008.15","article-title":"NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G","volume":"22","author":"Maki","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0270","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/eji.201141920","article-title":"4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia","volume":"42","author":"Buechele","year":"2012","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0275","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/CJI.0b013e3181e475e9","article-title":"Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 ex vivo expansion","volume":"33","author":"Xing","year":"2010","journal-title":"Journal of Immunotherapy"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0280","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2141.2008.07070.x","article-title":"Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia","volume":"141","author":"Palmer","year":"2008","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0285","first-page":"501","article-title":"Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS)","volume":"3","author":"Kimby","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1084\/jem.20020201","article-title":"Chemokine requirements for B cell entry to lymph nodes and Peyer's patches","volume":"196","author":"Okada","year":"2002","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0295","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2006.10.011","article-title":"Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes","volume":"25","author":"Bajenoff","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0300","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/416094a","article-title":"Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position","volume":"416","author":"Reif","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0305","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni1100","article-title":"Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5","volume":"5","author":"Allen","year":"2004","journal-title":"Nature Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0310","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/intimm\/dxq047","article-title":"Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses","volume":"22","author":"Pereira","year":"2010","journal-title":"International Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0315","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0320","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nature03703","article-title":"In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment","volume":"435","author":"Sipkins","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0325","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","article-title":"Lymphocyte homing and homeostasis","volume":"272","author":"Butcher","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0330","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.279.5349.381","article-title":"Chemokines and the arrest of lymphocytes rolling under flow conditions","volume":"279","author":"Campbell","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0335","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.leu.2401602","article-title":"Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)","volume":"13","author":"Mohle","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0340","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.leu.2402107","article-title":"Differential expression of chemokine receptors in B cell malignancies","volume":"15","author":"Durig","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0345","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00277-003-0679-0","article-title":"CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease","volume":"82","author":"Barretina","year":"2003","journal-title":"Annals of Hematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0350","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V99.8.2977","article-title":"The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes","volume":"99","author":"Till","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0355","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1182\/blood-2003-09-3103","article-title":"Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas","volume":"104","author":"Trentin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0360","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1182\/blood-2005-04-1718","article-title":"ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)","volume":"107","author":"Richardson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0365","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1073\/pnas.91.6.2305","article-title":"Molecular cloning and structure of a pre-B-cell growth-stimulating factor","volume":"91","author":"Nagasawa","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0370","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2141.2007.06790.x","article-title":"B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle","volume":"139","author":"Bennett","year":"2007","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0375","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1182\/blood-2009-05-219634","article-title":"In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia","volume":"114","author":"Calissano","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0380","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2009-03-212837","article-title":"B cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel Syk inhibitor, R406","volume":"114","author":"Quiroga","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0385","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1158\/0008-5472.CAN-08-4750","article-title":"Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease","volume":"69","author":"Vlad","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0390","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","article-title":"Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia","volume":"100","author":"Chen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0395","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1182\/blood-2007-06-094029","article-title":"CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential","volume":"110","author":"Deaglio","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0400","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/leu.2010.36","article-title":"CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells","volume":"24","author":"Vaisitti","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0405","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2004-12-4918","article-title":"Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells","volume":"106","author":"Burger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0410","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1182\/blood-2008-06-165068","article-title":"Isoform-selective phosphoinositide 3\u2032-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach","volume":"113","author":"Niedermeier","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0415","first-page":"27a","article-title":"Phosphoinositide 3\u2032-kinase (PI3K) delta inhibition with CAL-101 blocks B-cell receptor (BCR) signaling and the prosurvival actions of nurslike cells (NLC), in chronic lymphocytic leukemia","volume":"116","author":"Hoellenriegel","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0420","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood-2011-10-386417","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo","volume":"119","author":"Ponader","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0425","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2008-10-185827","article-title":"Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting","volume":"113","author":"Kurtova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0430","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnci\/92.8.628","article-title":"Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells","volume":"92","author":"Corcione","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0435","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ni1542","article-title":"Follicular shuttling of marginal zone B cells facilitates antigen transport","volume":"9","author":"Cinamon","year":"2008","journal-title":"Nature Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0440","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1600-065X.2003.00073.x","article-title":"The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity","volume":"195","author":"Muller","year":"2003","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0445","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0092-8674(00)81798-5","article-title":"A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen","volume":"87","author":"Forster","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0450","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nri2588","article-title":"Stromal cell contributions to the homeostasis and functionality of the immune system","volume":"9","author":"Mueller","year":"2009","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0455","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.1136736","article-title":"Imaging of germinal center selection events during affinity maturation","volume":"315","author":"Allen","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0460","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05573","article-title":"In vivo imaging of germinal centres reveals a dynamic open structure","volume":"446","author":"Schwickert","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0465","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1074-7613(01)00257-6","article-title":"CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity","volume":"16","author":"Ansel","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0470","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1084\/jem.177.6.1821","article-title":"Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes","volume":"177","author":"Schall","year":"1993","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0475","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.162.8.4455","article-title":"Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells","volume":"162","author":"Krzysiek","year":"1999","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0480","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1101\/sqb.1999.64.71","article-title":"The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes","volume":"64","author":"Alizadeh","year":"1999","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0485","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI40645","article-title":"Comprehensive assessment of chemokine expression profiles by flow cytometry","volume":"120","author":"Eberlein","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0490","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control","volume":"13","author":"Shaffer","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0495","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-08-4173","article-title":"CD38\/CD31, the CCL3 and CCL4 chemokines, and CD49d\/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival","volume":"69","author":"Zucchetto","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0500","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1182\/blood-2009-12-257758","article-title":"High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease","volume":"115","author":"Palacios","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0505","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2011-05-352492","article-title":"The phosphoinositide 3\u2032-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia","volume":"118","author":"Hoellenriegel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0510","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2010-09-307249","article-title":"CCL3 (MIP-1{alpha}) plasma levels and the risk for disease progression in chronic lymphocytic leukemia (CLL)","volume":"117","author":"Sivina","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0515","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2010.08152.x","article-title":"Monocytes\/macrophages but not T lymphocytes are the major targets of the CCL3\/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells","volume":"150","author":"Zucchetto","year":"2010","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0520","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1189\/jlb.0804460","article-title":"Targeting leukocyte integrins in human diseases","volume":"77","author":"Yonekawa","year":"2005","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0525","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1172\/JCI11092","article-title":"Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism","volume":"107","author":"Burger","year":"2001","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0530","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2011.369","article-title":"The CD49d\/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells","volume":"26","author":"Zucchetto","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0535","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood-2011-11-390989","article-title":"The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia","volume":"119","author":"de Rooij","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0540","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2007-05-092486","article-title":"Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia","volume":"111","author":"Gattei","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0545","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2141.2007.06965.x","article-title":"CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential","volume":"140","author":"Shanafelt","year":"2008","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0550","first-page":"251","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"Kuppers","year":"2005","journal-title":"Nature Reviews"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0555","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0560","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrd3937","article-title":"Targeting pathological B cell receptor signalling in lymphoid malignancies","volume":"12","author":"Young","year":"2013","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0565","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","article-title":"B-cell receptor signaling in chronic lymphocytic leukemia","volume":"118","author":"Stevenson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0570","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2012-02-362624","article-title":"The B-cell receptor signaling pathway as a therapeutic target in CLL","volume":"120","author":"Woyach","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0575","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0580","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2012-05-427534","article-title":"Self-antigen recognition by follicular lymphoma B-cell receptors","volume":"120","author":"Sachen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0585","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.4049\/jimmunol.1300179","article-title":"Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen","volume":"190","author":"Cha","year":"2013","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0590","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia","volume":"194","author":"Rosenwald","year":"2001","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0595","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1200\/JCO.2012.42.7906","article-title":"Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies","volume":"31","author":"Advani","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0600","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0605","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0610","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cr.2012.152","article-title":"Chronic lymphocytic leukemia: a tale of one or two signals","volume":"23","author":"Chiorazzi","year":"2013","journal-title":"Cell Research"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0615","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas","volume":"30","author":"Shaffer","year":"2012","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0620","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2141.2010.08244.x","article-title":"SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)","volume":"150","author":"Philippen","year":"2010","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0625","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","article-title":"Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity","volume":"115","author":"Herve","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0630","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0896-8411(88)90068-6","article-title":"Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies","volume":"1","author":"Broker","year":"1988","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0635","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.169.1.255","article-title":"Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia","volume":"169","author":"Sthoeger","year":"1989","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0640","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/blood.V76.3.562.562","article-title":"Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies","volume":"76","author":"Borche","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0645","doi-asserted-by":"crossref","first-page":"e15992","DOI":"10.1371\/journal.pone.0015992","article-title":"Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells","volume":"5","author":"Binder","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0650","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","article-title":"A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies","volume":"111","author":"Lanemo Myhrinder","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0655","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2009-09-244251","article-title":"Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin","volume":"115","author":"Chu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0660","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2119\/2008-00102.Catera","article-title":"Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation","volume":"14","author":"Catera","year":"2008","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0665","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20121801","article-title":"A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi","volume":"210","author":"Hoogeboom","year":"2013","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0670","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"Duhren-von Minden","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0675","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood-2012-09-454439","article-title":"CLL B-cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLL","volume":"121","author":"Binder","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0680","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1002\/eji.1830241228","article-title":"Expression of Bruton's tyrosine kinase protein within the B cell lineage","volume":"24","author":"Genevier","year":"1994","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0685","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0690","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-2660(08)60448-4","article-title":"Molecular basis for X-linked immunodeficiencies","volume":"35","author":"Smith","year":"1997","journal-title":"Advances in Genetics"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0695","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.191.10.1745","article-title":"Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement","volume":"191","author":"Petro","year":"2000","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0700","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1084\/jem.20011866","article-title":"The B cell antigen receptor controls integrin activity through Btk and PLCgamma2","volume":"198","author":"Spaargaren","year":"2003","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0705","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/eji.200535799","article-title":"Roles for phosphoinositide 3-kinases, Bruton's tyrosine kinase, and Jun kinases in B lymphocyte chemotaxis and homing","volume":"36","author":"Ortolano","year":"2006","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0710","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.immuni.2006.11.012","article-title":"Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing","volume":"26","author":"de Gorter","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0715","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0720","doi-asserted-by":"crossref","DOI":"10.3109\/10428194.2013.777837","article-title":"Emerging drug profiles: Bruton tyrosine kinase (BTK) inhibitor ibrutinib (PCI-32765)","author":"Burger","year":"2013","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0725","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0730","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton's tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0735","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0740","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2012-08-452607","article-title":"Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling","volume":"121","author":"Burger","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0745","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","article-title":"PI3 kinase signals BCR-dependent mature B cell survival","volume":"139","author":"Srinivasan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0750","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri1056","article-title":"PI3K in lymphocyte development, differentiation and activation","volume":"3","author":"Okkenhaug","year":"2003","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0755","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1128\/MCB.22.24.8580-8591.2002","article-title":"Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex","volume":"22","author":"Jou","year":"2002","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0760","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1073560","article-title":"Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice","volume":"297","author":"Okkenhaug","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0765","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1182\/blood-2002-02-0539","article-title":"Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta","volume":"100","author":"Ringshausen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0770","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1182\/blood-2005-04-1483","article-title":"Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes","volume":"107","author":"Kienle","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0775","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.leukres.2008.03.003","article-title":"Bone marrow fibroblasts induce expression of PI3K\/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells","volume":"32","author":"Edelmann","year":"2008","journal-title":"Leukemia Research"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0780","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","article-title":"The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells","volume":"111","author":"Longo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0785","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2010-03-275305","article-title":"CAL-101, a p110{delta} selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability","volume":"117","author":"Lannutti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0790","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1182\/blood-2010-02-271171","article-title":"Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals","volume":"116","author":"Herman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0795","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2009-06-222943","article-title":"PI3K\/p110{delta} is a novel therapeutic target in multiple myeloma","volume":"116","author":"Ikeda","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0800","doi-asserted-by":"crossref","first-page":"31a","DOI":"10.1182\/blood.V116.21.55.55","article-title":"CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3-kinase P110{delta}, demonstrates clinical activity and pharmacodynamic effects in patients with relapsed or refractory chronic lymphocytic leukemia","volume":"116","author":"Furman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0805","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/378298a0","article-title":"Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk","volume":"378","author":"Turner","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0810","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/378303a0","article-title":"Syk tyrosine kinase required for mouse viability and B-cell development","volume":"378","author":"Cheng","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0815","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1182\/blood-2008-05-158618","article-title":"Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target","volume":"113","author":"Young","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0820","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.immuni.2007.04.011","article-title":"Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1","volume":"26","author":"Zarbock","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0825","doi-asserted-by":"crossref","first-page":"17263","DOI":"10.1074\/jbc.M000689200","article-title":"Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk","volume":"275","author":"Ganju","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0830","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/art.23992","article-title":"Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial","volume":"58","author":"Weinblatt","year":"2008","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0835","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0840","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1000500","article-title":"An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis","volume":"363","author":"Weinblatt","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0845","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2012.24","article-title":"Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration","volume":"26","author":"Hoellenriegel","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0850","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2012-08-452607","article-title":"Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B cell receptor signaling","volume":"121","author":"Burger","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0855","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/leu.2008.299","article-title":"CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers","volume":"23","author":"Burger","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0860","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2133.2006.07150.x","article-title":"CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma","volume":"154","author":"Chen","year":"2006","journal-title":"The British Journal of Dermatology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0865","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/01.qai.0000137371.80695.ef","article-title":"Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection","volume":"37","author":"Hendrix","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0870","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0875","article-title":"Preliminary results from a phase I\/II dose escalation study to determine the maximum tolerated dose of plerixafor in combination with rituximab in patients with relapsed chronic lymphocytic leukemia","volume":"95","author":"Andritsos","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0880","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nri2635","article-title":"Engineering lymphocyte subsets: tools, trials and tribulations","volume":"9","author":"June","year":"2009","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0885","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0890","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0895","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0900","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0905","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1172\/JCI46110","article-title":"CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients","volume":"121","author":"Savoldo","year":"2011","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0910","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-13-0330","article-title":"Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells","volume":"19","author":"Hudecek","year":"2013","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0915","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3324\/haematol.2012.077537","article-title":"The PD-1\/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia","volume":"98","author":"Brusa","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0920","first-page":"252","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nature Reviews"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0925","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/1078-0432.CCR-07-4079","article-title":"Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies","volume":"14","author":"Berger","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0930","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.177.4.925","article-title":"Activated T cells induce expression of B7\/BB1 on normal or leukemic B cells through a CD40-dependent signal","volume":"177","author":"Ranheim","year":"1993","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0935","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1158\/0008-5472.CAN-11-3368","article-title":"Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 molecule","volume":"72","author":"Castro","year":"2012","journal-title":"Cancer Research"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0940","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/leu.2010.191","article-title":"A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154","volume":"24","author":"Wierda","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0945","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1200\/JCO.2010.29.8133","article-title":"Single-agent lenalidomide in the treatment of previously untreated chronic lymphocytic leukemia","volume":"29","author":"Chen","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0950","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2011-03-339077","article-title":"Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia","volume":"118","author":"Badoux","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0955","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2012.42.8623","article-title":"Phase II study of lenalidomide and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemia","volume":"31","author":"Badoux","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0960","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1182\/blood-2012-12-470005","article-title":"Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)","volume":"121","author":"Shanafelt","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.08.011_bib0965","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3324\/haematol.2009.009274","article-title":"Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug","volume":"94","author":"Ramsay","year":"2009","journal-title":"Haematologica"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:04:30Z","timestamp":1715969070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X13000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":193,"alternative-id":["S1044579X13000874"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.08.011","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}